Syngene International, a leading global CRDMO, is excited to announce its participation in the Animal Health, Nutrition, and Technology Innovation (AHNTI) Event 2025, taking place from 10-12 February at Intercontinental London – O2 in London, UK.
Syngene will be exhibiting at Booth #21, where the company will showcase its expertise in end-to-end solutions for animal health drug innovation and manufacturing, including small molecules, biologics, and veterinary vaccines. Leveraging India’s cost-effective advantage and state-of-the-art facilities, Syngene ensures high-quality, scalable solutions to meet global industry needs.
Key highlights
- Innovation and manufacturing excellence: Comprehensive support from preclinical research to species-specific formulations and innovative delivery systems, such as microencapsulation and commercial-scale production bringing innovation from concept to clinic.
- Credibility and expertise: Years of experience partnering with top leading animal health companies to deliver reliable, high-quality solutions.
- Supply chain excellence and India advantage: Leveraging India’s robust infrastructure for cost-effective manufacturing and seamless global supply chain management.
- Sustainability-driven solutions: Advanced manufacturing practices focused on quality and sustainability.
Book a meeting with Syngene International at AHNTI Europe 2025 to explore their end-to-end solutions designed to accelerate innovation and drive success in animal health.